{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-016120","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.321171+00:00","generated_at":"2026-05-19T00:11:55.556827+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Immix Biopharma stockholders elect 8 directors and ratify Crowe LLP as 2025 auditor","bullets":["All 8 director nominees elected with 'for' votes ranging from 13.4M to 14.6M; broker non-votes 5.5M across all director proposals.","Ratification of Crowe LLP as independent auditor approved with 19.9M for, 47.6K against, 98.4K abstentions (no broker non-votes).","72.1% of outstanding shares (20.1M) were present or represented at the June 20, 2025 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-016120","json":"https://secwatch.observer/filing/0001641172-25-016120.json","markdown":"https://secwatch.observer/filing/0001641172-25-016120.md","text":"https://secwatch.observer/filing/0001641172-25-016120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225016120/0001641172-25-016120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225016120/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T00:11:55.556827+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}